Glaxo: Good Show - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Glaxo: Good Show

Apr 27, 2001

Glaxo India Ltd has posted a net profit of Rs 102 m (down 28%) for the quarter ended March 31, 2001. Net sales grew by 6.1% to Rs 1,944 m compared to Rs 1,832 m in the corresponding period last fiscal. Operating margins showed a significant improvement, increasing by more than 60 basis points. The dip in net profits was primarily due to comparatively lower other income. Other Income for the corresponding previous period last year included a income Rs 50 m from sale of brands. Barring Other Income, Profit Before Tax has in effect increased by more than 22.9%

(Rs m) 1QFY01 1QFY02 Change
Sales 1,832 1,944 6.1%
Other Income 130 64 -50.8%
Expenditure 1,689 1,781 5.4%
Operating Profit (EBDIT) 143 163 14.0%
Operating Profit Margin (%) 7.8% 8.4%  
Interest 21 23 9.5%
Depreciation 39 38 -2.6%
Profit before Tax 213 166 -22.1%
Other Adjustments      
Tax 72 64 -11.1%
Profit after Tax/(Loss) 141 102 -27.7%
Net profit margin (%) 7.7% 5.2%  
No. of Shares (eoy) (m) 60 60  
Diluted Earnings per share* 9.4 6.8  
P/E (at current price) 40.9 56.6  
(*- annualised)      

The company has also received approval of the shareholders to merge Smithkline Beecham Pharma with effect from 12th April 2001.

In a related development the company recently decided to expand the business activities of its animal health division by entering new areas like antibiotic and ectoparasite and nutrition segments, launching technically superior products in cattle and poultry segment besides launching line extension of existing products.The animal healthmarket in the country is estimated to be around Rs 8 bn with the poultry sector alone contributing 45%.

At the current market price of Rs 386, the stock is trading at 57 times its annualised 1QFY02 earnings.

Equitymaster requests your view! Post a comment on "Glaxo: Good Show". Click here!


More Views on News

GSK PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 2.2% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, GSK PHARMA has posted a net profit of Rs 1 bn (down 2.2% YoY). Sales on the other hand came in at Rs 6 bn (down 17.7% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 398.9% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, GSK PHARMA has posted a net profit of Rs 5 bn (up 398.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

More Views on News

Most Popular

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers (Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.

My Top Stock to Buy in this Market Selloff (Profit Hunter)

Sep 22, 2020

The recent correction offers a great opportunity to buy this high conviction smallcap stock.

Can the Nifty Fall to 10,200? (Fast Profits Daily)

Sep 24, 2020

The Nifty has reached an important support level today. If it breaks then we could see further downside.

What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...


Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms


Sep 30, 2020 01:45 PM


  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks